O
TNDM icon

OrbiMed’s Tandem Diabetes Care TNDM Stock Holding History

OrbiMed’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,141,390
Closed -$68M – 160
2019
Q4 		$68M Buy
1,141,390
+477,000
+72% +$29.4M 0.97% 37
2019
Q3 		$39.2M Buy
664,390
+93,600
+16% +$5.97M 0.74% 44
2019
Q2 		$36.8M Sell
570,790
-60,510
-10% -$3.91M 0.57% 49
2019
Q1 		$40.1M Sell
631,300
-316,700
-33% -$16.6M 0.62% 47
2018
Q4 		$36M Buy
948,000
+233,500
+33% +$8.25M 0.67% 48
2018
Q3 		$30.6M Sell
714,500
-974,500
-58% -$34M 0.37% 69
2018
Q2 		$37.2M Buy
+1,689,000
New +$20.8M 0.44% 61

Other funds holding TNDM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

OrbiMed's TNDM Position: Q1 2020 in Review

OrbiMed sold out of Tandem Diabetes Care (TNDM) in Q1 2020, closing a stake of 1,141,390 shares — an estimated $68M sold.

OrbiMed first reported a position in TNDM in Q2 2018 and held it in 7 quarters. The position peaked at $68M in Q4 2019. 279 funds tracked by Wall St. Rank hold TNDM as of Q1 2020.

  • OrbiMed reported no remaining Tandem Diabetes Care position as of Q1 2020 after selling out during the quarter.
  • OrbiMed sold 1,141,390 Tandem Diabetes Care shares in Q1 2020, an estimated $68M.
  • OrbiMed first reported a position in Tandem Diabetes Care in Q2 2018 and held it in 7 quarters.
  • OrbiMed's Tandem Diabetes Care position peaked at $68M in Q4 2019.
  • 279 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2020.

Based on OrbiMed's 13F filing for Q1 2020, filed 15 May 2020.